State Street Corp Biogen Inc. Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

A detailed history of State Street Corp transactions in Biogen Inc. stock. As of the latest transaction made, State Street Corp holds 7,096,018 shares of BIIB stock, worth $1.23 Billion. This represents 0.07% of its overall portfolio holdings.

Number of Shares

7,096,018

Previous 6,747,008 5.17%

Holding current value

$1.23 Billion

Previous $1.45 Billion 13.07%

% of portfolio

0.07%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $66.5 Million - $82.6 Million	349,010 Added 5.17%	7,096,018 $1.64 Billion
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $42.1 Million - $53.2 Million	-198,657 Reduced 2.86%	6,747,008 $1.45 Billion
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $17.8 Million - $21.4 Million	80,011 Added 1.17%	6,945,665 $1.8 Billion
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $4.95 Million - $5.59 Million	-19,561 Reduced 0.28%	6,865,654 $1.76 Billion
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $35.3 Million - $40.8 Million	128,215 Added 1.9%	6,885,215 $1.96 Billion
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $13.2 Million - $15 Million	-51,274 Reduced 0.75%	6,757,000 $1.88 Billion
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $22 Million - $26.7 Million	-87,083 Reduced 1.26%	6,808,274 $1.89 Billion
Q3 2022 Nov 15, 2022	BUY	$194.69 - $268.46 $3.6 Million - $4.96 Million	18,476 Added 0.27%	6,895,357 $1.84 Billion
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $62.3 Million - $74 Million	-332,025 Reduced 4.61%	6,876,881 $1.4 Billion
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $38.3 Million - $48.2 Million	197,400 Added 2.82%	7,208,906 $1.52 Billion
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $24.2 Million - $31.1 Million	107,970 Added 1.56%	7,011,506 $1.68 Billion
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $63.2 Million - $82.5 Million	223,496 Added 3.35%	6,903,536 $1.95 Billion
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $1.94 Million - $3.11 Million	7,507 Added 0.11%	6,680,040 $2.31 Billion
Q1 2021 May 17, 2021	SELL	$242.95 - $284.63 $77.6 Million - $90.9 Million	-319,482 Reduced 4.57%	6,672,533 $1.87 Billion
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $126 Million - $189 Million	-531,681 Reduced 7.07%	6,992,015 $1.71 Billion
Q3 2020 Nov 10, 2020	SELL	$264.77 - $305.71 $82.9 Million - $95.7 Million	-313,177 Reduced 4.0%	7,523,696 $2.13 Billion
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $110 Million - $146 Million	-425,369 Reduced 5.15%	7,836,873 $2.1 Billion
Q1 2020 May 11, 2020	BUY	$268.85 - $341.04 $2.22 Billion - $2.82 Billion	8,262,242 New	8,262,242 $2.61 Billion

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Biogen Inc. Transaction History